Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
mRNA | EMC6 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-08 |
mRNA | SCAMP3 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | UTP3 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
mRNA | POU2AF1 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
mRNA | DEF8 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | KIF1C | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-06 |
mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
mRNA | MRPS18B | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |